Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Haematologica|May 4, 2019
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditionsPeter Valent, Attilio Orazi, Michael R Savona, et al.
Haematologica|October 26, 2014
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Uwe Platzbecker, Catharina Müller-Thomas, et al.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Blood|June 24, 2016
Time-dependent changes in mortality and transformation risk in MDSMichael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, et al.
Blood|June 29, 2012
Revised international prognostic scoring system for myelodysplastic syndromesPeter L Greenberg, Heinz Tuechler, Julie Schanz, et al.
Leukemia Research|September 17, 2018
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDSYasushi Miyazaki, Heinz Tuechler, Guillermo Sanz, et al.
Haematologica|June 24, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromesArjan A van de Loosdrecht, Canan Alhan, Marie Christine Béné, et al.
Blood|July 29, 2024
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletionMaria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.
Blood|April 30, 2020
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDSLuca Malcovati, Kristen Stevenson, Elli Papaemmanuil, et al.
Leukemia|August 5, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance studyElena Crisà, Elvira Mora, Ulrich Germing, et al.
Pageof 10